Xia et al. reported that ERK5 acts as a substrate for microRNA-143-3p (miR-143-3p), which downregulates ERK5 expression, thereby inhibiting the proliferation, migration, and invasion of breast cancer cells [58]. Here, MAPK7 is linked to breast carcinoma.